spesolimab-sbzo

spesolimab-sbzo (SPEVIGO) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.

SPEVIGO is a marketed brand name for spesolimab-sbzo. Check FDA Drugs@FDA for the current US label holder and prescribing information.

spesolimab-sbzo has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.